Sun Pharma slips over 2% on recall of osteoporosis drug in US
The recall of 3,81,120 cartons of Alendronate Sodium tablets has been initiated by Sun Pharma Global Fze, an arm of the Indian pharma major.
By ET Online |
NEW DELHI: Sun Pharma slipped as much as 2.4 per cent in morning trade on Friday, after the pharma major recalled around 3.8 lakh cartons of an osteoporosis drug in the US and Puerto Rico due to presence of 'unknown impurity'.
At 09:40 am, Sun Pharma was trading 1.6 per cent lower at Rs 851.25. It hit a low of Rs 844.20, and a high of Rs 855.50 in trade today.
The recall of 3,81,120 cartons of Alendronate Sodium tablets has been initiated by Sun Pharma Global Fze, an arm of the Indian pharma major.
The drug is manufactured at Sun Pharma's Halol facility in Gujarat, United States Food and Drug Administration (USFDA) said in its latest Enforcement Report.
At 09:40 am, Sun Pharma was trading 1.6 per cent lower at Rs 851.25. It hit a low of Rs 844.20, and a high of Rs 855.50 in trade today.
The recall of 3,81,120 cartons of Alendronate Sodium tablets has been initiated by Sun Pharma Global Fze, an arm of the Indian pharma major.
The drug is manufactured at Sun Pharma's Halol facility in Gujarat, United States Food and Drug Administration (USFDA) said in its latest Enforcement Report.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
